Kathleen Sanzo

The FDA published a final rule on FDA’s standards for accepting data from clinical investigations for medical devices on February 21.

The FDA's new draft IVD Guidelines will need to be factored into how pharma clinical trial sponsors use IVDs in a clinical trial, study design, timeline for protocol development, IND submission, and study initiation.